Assoc. Prof. Dr. Eman El-Wakil , Theodor Bilharz Research Institute , Egypt
Dr. Eman Sayed Shabrawy El-Wakil is an Associate Professor and Consultant of Medical Parasitology at the Theodor Bilharz Research Institute (TBRI), Egypt. Born on November 21, 1985, she has been deeply engaged in research and diagnostics of parasitic diseases, particularly focusing on molecular characterization, novel therapeutics, and gut microbiota-parasite interaction. With multiple peer-reviewed publications, she contributes to advancing parasitological science both in Egypt and internationally. She earned her M.D. in Medical Parasitology from Cairo University, and her scholarly reputation is supported by memberships and indexed profiles on ResearchGate, Google Scholar, Scopus, and ORCID. Dr. El-Wakil’s work has received notable accolades, including the prestigious TBRI award for the best doctoral research. She is also a reviewer for multiple journals and collaborates on multidisciplinary research tackling emerging parasitic threats. Her vision integrates research, education, and public health improvement through evidence-based parasitology.
Publication Profile:
Scopus
✅ Strengths for the Award:
Dr. Eman Sayed Shabrawy El-Wakil stands out as a prominent figure in Medical Parasitology, with an impressive track record in research, publication, and applied therapeutics. Her strengths include:
-
Robust Research Output: With over 12 peer-reviewed publications in high-impact international journals between 2023–2025, her work addresses critical parasitic diseases like Cryptosporidiosis, Trichinellosis, Toxoplasmosis, and Entamoeba infections.
-
Innovative Methodologies: She has pioneered green synthesis, nanoparticle-based therapies, in silico modeling, and immunomodulatory strategies, showcasing her multidimensional expertise.
-
Academic Leadership: As an Associate Professor and Consultant at TBRI, she contributes to teaching, mentoring, and national public health research priorities.
-
International Recognition: Indexed in Scopus, Google Scholar, ORCID, and Web of Science, and recipient of the TBRI Award for the best doctoral research in 2021.
-
Interdisciplinary Collaboration: Engaged in research across nanomedicine, pharmacology, microbiota-parasite interactions, and immunotherapy.
🔍 Areas for Improvement:
While Dr. El-Wakil’s profile is distinguished, some areas can be enhanced to strengthen her global impact:
-
Increased Global Engagement: Participation in more international collaborative projects, conferences, and consortia would amplify the reach of her research.
-
Grant Acquisition: Pursuing competitive research funding (e.g., WHO, NIH, EU Horizon) would facilitate larger-scale studies and clinical applications.
-
Patents and Translational Outputs: Exploring patenting opportunities for her innovative therapeutic agents could position her as a translational research leader.
🎓 Education:
Dr. El-Wakil earned her Master’s (M.Sc.) in Medical Parasitology with Excellent distinction in May 2015, and her Doctorate (M.D.) in Medical Parasitology in May 2018 from the Faculty of Medicine, Cairo University. Her educational path is marked by excellence in theoretical and applied parasitology, encompassing key disciplines like Molecular Parasitology, Immunology, and Medical Parasitology. Her M.D. thesis, titled “Isolation and Molecular Characterization of Free-Living Amoebae from Water Sources in Egypt”, reflected her early interest in environmental parasitology and public health. The academic structure of her doctoral program integrated critical courses in host-parasite interactions and advanced diagnostic techniques, equipping her with both field and laboratory expertise. Her education established a strong foundation for a career defined by innovation, critical thinking, and translational research in parasitic diseases.
💼 Experience:
Currently serving as an Associate Professor and Consultant at TBRI’s Parasitology Department, Dr. El-Wakil brings over a decade of expertise in diagnostics, molecular biology, and experimental parasitology. She operates within the Immunology and Drug Evaluation Division, where she contributes to therapeutic investigations and drug repurposing studies targeting helminths and protozoa. Her consultancy role extends to research mentorship, scientific reviews, and diagnostic innovations for parasitic infections in Egypt. She also works closely with governmental and academic institutions under the Ministry of Higher Education and Scientific Research. Her leadership roles in various inter-institutional projects have propelled the institute’s visibility in parasitology. She also manages collaborations involving nanotechnology, bioinformatics, and herbal medicine as potential parasitic treatments. Dr. El-Wakil exemplifies a blend of academic rigor and applied science, aligning her role with national health priorities and global research trends.
🏅 Honors and Awards:
Dr. El-Wakil was honored with the Theodor Bilharz Research Institute Award in 2021 for the best research derived from a doctoral dissertation—an acknowledgment of her innovation in parasitological research. This award recognized her pioneering work on free-living amoebae and her methodological precision. In addition to institutional awards, her research has been showcased in multiple open-access international journals, and she frequently receives commendations for excellence in experimental design and publication impact. Her work on novel anti-parasitic agents and immunotherapeutic approaches has attracted attention in scientific forums. She has also contributed to multi-author reviews on global health topics such as SARS-CoV-2 vaccines, highlighting her versatility as a researcher. Her awards reflect both her depth of knowledge and the real-world applicability of her research in enhancing public health outcomes.
🔬 Research Focus:
Dr. El-Wakil’s research concentrates on the epidemiology, molecular diagnostics, and therapeutic strategies for parasitic infections. Her work integrates natural product pharmacology, nanotechnology-based delivery systems, and immune modulation therapies. Her investigations cover a broad spectrum of parasites, from protozoa like Cryptosporidium and Entamoeba, to helminths such as Trichinella spiralis. Recent research includes green synthesis of nanoparticles, bioinformatics-based molecular docking, and gut microbiota-parasite interactions. A recurring theme in her research is the repurposing of existing drugs for parasitic treatment, evaluated both in vitro and in vivo. She also explores the interplay between host immunity and parasitic infection using molecular signaling pathways such as P2X7 receptors. Her focus on translational parasitology bridges basic research and therapeutic innovation, providing insights into both endemic and emerging infections in Egypt and beyond.
📚 Publications Top Notes:
-
🍊 Green Synthesis of Chitosan/Silver Nanoparticles Using Citrus paradisi Extract and Its Potential Anti-Cryptosporidiosis Effect
-
🧬 Microbiota-Parasite Interaction: Implication of Secretory Immunoglobulin A and P2X7 Receptor Signaling
-
🌿 Repurposing Drugs to Treat Trichinellosis: In Vitro Analysis of Nifedipine and Chrysanthemum coronarium Extract
-
🧪 Prevalence and Molecular Identification of Entamoeba Species Complex in Egyptians
-
📊 Mapping Gut Parasitism Patterns in a Cohort of Egyptians
-
🍃 Annona Muricata Leaf as an Anti-Cryptosporidial Agent: In Silico and In Vivo Study
-
🌼 Prophylactic and Therapeutic Effects of Kaempferol on Experimental Trichinella Spiralis
-
💊 Surfactant Vesicles for Enhanced Antitoxoplasmic Effect of Norfloxacin
-
🧾 SARS-CoV-2 Vaccines from A to Z: A Review of the Current Challenges
-
💉 Albendazole and Berberine Nanoparticles in Experimental Trichinellosis
-
🌿 Therapeutic Efficacy of Silymarin on Intestinal and Muscular Phases of Trichinellosis
-
🧫 Trichinella spiralis Antigens for Inflammatory Bowel Disease: Immunotherapeutic and Prophylactic Potential
🧾 Conclusion:
Dr. Eman S. El-Wakil demonstrates excellence in research productivity, scientific innovation, and professional engagement. Her contributions to parasitology—especially in the field of therapeutic innovation using natural compounds and nanoparticles—mark her as an emerging leader in her field. Given her academic rigor, publication record, and commitment to tackling parasitic diseases of global health concern, she is an outstanding candidate for the Best Researcher Award.